Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood.
暂无分享，去创建一个
M. Renatus | M. Wartmann | S. Melkko | T. Radimerski | M. Blatter | T. Wagner | C. Régnier | P. Erbel | Jean Quancard | A. Schlapbach | M. Bigaud | P. Mcsheehy | Carole Pissot Soldermann | A. Weiss | R. Endres | F. Bornancin | K. Beltz | T. Calzascia | L. Kieffer | Mickael Sorge | R. Aichholz | O. Simić | C. Regnier | Karen Beltz | Samu Melkko